Axonics (NASDAQ:AXNX) Price Target Raised to $76.00 at Needham & Company LLC

Axonics (NASDAQ:AXNX – Free Report) had its target price raised by Needham & Company LLC from $73.00 to $76.00 in a research note issued to investors on Friday, MarketBeat Ratings reports. Needham & Company LLC currently has a buy rating on the stock. A number of other equities research analysts also recently weighed in on […]

Related Keywords

Hong Kong ,Canada ,Dannyl Dearen ,Robertw Baird , ,Needham Company ,Tower Research Capital ,Almanack Investment Partners ,Nasdaq ,Royal Bank ,Axonics Company Profile ,Hong Kong Ltd ,Axonics Inc ,Arcadia Investment Management Corp ,Keycorp ,Free Report ,Marketbeat Ratings ,Truist Financial ,Moderate Buy ,Get Free Report ,Investment Partners ,Financial Advisors ,Research Capital ,Kong Ltd ,Axonics Daily ,Axonics ,Nasdaq Axnx ,Axnx ,Medical ,Boost Price Target ,Needham Company Llc ,